Stock 603392 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Equities

603392

CNE100004090

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
66.72 CNY -0.83% Intraday chart for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. -13.51% -11.19%
Apr. 12 Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected' MT
Mar. 29 Wantai BioPharm's 2023 Profit Drops 74% on Revenue Drop; Shares Slump 3% MT

Business Summary

Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Company is also engaged in the sales of agent products. The in-vitro diagnostics include: enzyme-linked immunosorbent assay (ELISA) reagents, chemiluminescence reagents, biochemical reagents and quality control products. The in-vitro diagnostic instruments mainly include the automatic chemiluminescence immunoassay analyzer. The primary product of vaccine products is Hecolin used for hepatitis E. The agent products are in-vitro diagnostics and in-vitro diagnostic equipment from Bio-Rad Laboratories Inc in the U.S. and Diagast SAS in France.

Number of employees: 3,843

Sales per Business

CNY in Million2022Weight2023Weight Delta
Vaccine
71.9 %
8,493 75.9 % 3,960 71.9 % -53.37%
Diagnostic
32.8 %
2,884 25.8 % 1,810 32.8 % -37.24%
Inter-segment Elimination
-5.0 %
-210 -1.9 % -276 -5.0 % +31.90%
Other Business
0.3 %
19 0.2 % 17 0.3 % -6.56%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
97.2 %
10,720 96.0 % 5,342 97.2 % -50.17%
Overseas
2.8 %
446 4.0 % 151 2.8 % -66.06%

Managers

Managers TitleAgeSince
Yi Yong Zhao DFI
 Director of Finance/CFO 53 07-12-31
Zi Xin Qiu CHM
 Chairman 60 96-12-31
Hao Chen ADM
 Chief Administrative Officer 42 06-12-31
Yi Min Li CTO
 Chief Tech/Sci/R&D Officer 66 99-12-31
Cun Ren Chen BRD
 Director/Board Member 41 08-12-31
Xiang Zhong Ye BRD
 Director/Board Member 57 18-05-03
Ling Zhi Zhao BRD
 Director/Board Member 61 18-05-03
Shu Ling Zhao IRC
 Investor Relations Contact - -
Tao Yu SEC
 Corporate Secretary 49 06-12-31

Members of the board

Members of the board TitleAgeSince
Zi Xin Qiu CHM
 Chairman 60 96-12-31
Gui Qiang Wang BRD
 Director/Board Member 61 18-04-12
Yi Min Li
66 -
Qing Chao Xing CHM
 Chairman 39 18-04-12
Zhi Gang Zhao BRD
 Director/Board Member 46 22-05-04
Ling Zhi Zhao BRD
 Director/Board Member 61 18-05-03
Xiang Zhong Ye BRD
 Director/Board Member 57 18-05-03
Hui Qiang Xing BRD
 Director/Board Member 48 21-01-28
Dan Wang BRD
 Director/Board Member 58 21-04-14
Cun Ren Chen BRD
 Director/Board Member 41 08-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,270,426,434 231,234,244 ( 18.20 %) 2,219,435 ( 0.1747 %) 18.20 %

Shareholders

NameEquities%Valuation
Shan Shan Zhong
73.52 %
929,758,999 73.52 % 8 701 M ¥
Zi Xin Qiu
3.546 %
44,846,760 3.546 % 420 M ¥
Jing Lin Ding
1.257 %
15,894,057 1.257 % 149 M ¥
Fortune & Royal Asset Management Co., Ltd.
1.227 %
15,517,621 1.227 % 145 M ¥
Wei Gang Hong
1.179 %
14,904,816 1.179 % 139 M ¥
Ming Jing Qiu
1.109 %
14,019,000 1.109 % 131 M ¥
Generali China Asset Management Co. Ltd.
0.8181 %
10,345,082 0.8181 % 97 M ¥
Sha Yan Li
0.7673 %
9,703,563 0.7673 % 91 M ¥
China Merchants Fund Management Co., Ltd.
0.6127 %
7,748,645 0.6127 % 73 M ¥
Yi Min Li
0.5999 %
7,585,938 0.5999 % 71 M ¥

Holdings

NameEquities%Valuation
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
0.18%
 2,219,448 0.18% 20,771,281 $

Company contact information

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

No. 31 Science Park Road Changping District

102206, Beijing

+86 10 5952 8888

http://www.ystwt.com
address Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.(603392)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
66.72 CNY
Average target price
75.15 CNY
Spread / Average Target
+12.64%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.19% 11.79B
CSL LIMITED Stock CSL Limited
-5.99% 84.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.85B
BIOGEN INC. Stock Biogen Inc.
-24.88% 27.69B
UCB Stock UCB
+53.61% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-8.08% 17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-33.74% 13.67B
INCYTE CORPORATION Stock Incyte Corporation
-16.63% 11.86B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-2.25% 8.07B
INTRA-CELLULAR THERAPIES, INC. Stock Intra-Cellular Therapies, Inc.
+1.05% 7.51B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 603392 Stock
  4. Company Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.